Favourable long-term outcome of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy

被引：0
|
作者：
Welge, D.
Faber, L.
Fassbender, D.
Schmidt, H. K.
Gleichmann, U.
Seggewiss, H.
Horstkotte, D.
机构：
[1] N Rhine Westphalia, Bad Oeynhausen, Germany
[2] Leopoldina Hosp, Schweinfurt, Germany
来源：
EUROPEAN HEART JOURNAL | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：956 / 956
页数：1
相关论文
共 50 条
  • [31] LONG-TERM EFFICIENCY OF PERCUTANEOUS TRANSLUMINAL SEPTAL MYOCARDIAL ABLATION FOR HYPERTROPHIC OBSTRACTIVE CARDIOMYOPATHY
    Xiaozeng, W.
    Xing-Xing, L.
    Jie, D.
    Ruo-Xi, G.
    Ya-Ling, H.
    HEART, 2015, 101 : A26 - A26
  • [32] Long-term outcome after septal alcohol ablation in symptomatic patients with obstructive cardiomyopathy: a single center experience
    Hage, F.
    Morice, M. C.
    Cheaito, R.
    Cormier, B.
    Watanabe, Y.
    Louvard, Y.
    Garot, P.
    Piechaud, J. F.
    Lefevre, T.
    EUROPEAN HEART JOURNAL, 2014, 35 : 926 - 926
  • [33] Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy
    Sorajja, Paul
    Valeti, Uma
    Nishimura, Rick A.
    Ommen, Steve R.
    Rihal, Charanjit S.
    Gersh, Bernard J.
    Hodge, David O.
    Schaff, Hartzell V.
    Holmes, David R., Jr.
    CIRCULATION, 2008, 118 (02) : 131 - 139
  • [34] Alcohol Septal Ablation for Treatment of Symptomatic Hypertrophic Obstructive Cardiomyopathy
    Messenger J.C.
    Salcedo E.E.
    Current Cardiovascular Risk Reports, 2017, 11 (5)
  • [35] Long-term recovery of atrioventricular conduction after percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy
    Axelsson, A.
    Weibring, K.
    Havndrup, O.
    Kelbak, H.
    Jorgensen, E.
    Helqvist, S.
    Kober, L.
    Bundgaard, H.
    Jensen, M. K.
    EUROPEAN HEART JOURNAL, 2012, 33 : 738 - 738
  • [36] Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry
    Veselka, Josef
    Faber, Lothar
    Liebregts, Max
    Cooper, Robert
    Januska, Jaroslav
    Krejci, Jan
    Bartel, Thomas
    Dabrowski, Maciej
    Hansen, Peter Riis
    Almaas, Vibeke Marie
    Seggewiss, Hubert
    Horstkotte, Dieter
    Adlova, Radka
    Bundgaard, Henning
    ten Berg, Jurrien
    Stables, Rodney Hilton
    Jensen, Morten Kvistholm
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (05):
  • [37] Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy
    Amelie Burghardt
    Frank van Buuren
    Zisis Dimitriadis
    Tim Grübbel
    Hubert Seggewiss
    Smita Scholtz
    Dieter Horstkotte
    Lothar Faber
    Clinical Research in Cardiology, 2018, 107 : 479 - 486
  • [38] Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy
    Burghardt, Amelie
    van Buuren, Frank
    Dimitriadis, Zisis
    Gruebbel, Tim
    Seggewiss, Hubert
    Scholtz, Smita
    Horstkotte, Dieter
    Faber, Lothar
    CLINICAL RESEARCH IN CARDIOLOGY, 2018, 107 (06) : 479 - 486
  • [39] Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy
    Sedehi, Daniel
    Finocchiaro, Gherardo
    Tibayan, Yen
    Chi, Jeffrey
    Pavlovic, Aleksandra
    Kim, Young M.
    Tibayan, Frederick A.
    Reitz, Bruce A.
    Robbins, Robert C.
    Woo, Joseph
    Ha, Richard
    Lee, David P.
    Ashley, Euan A.
    JOURNAL OF CARDIOLOGY, 2015, 66 (1-2) : 57 - 62
  • [40] Predictors of long-term outcome after rescue surgical septal myectomy in hypertrophic obstructive cardiomyopathy patients with previous alcohol septal ablation
    Zhu, C.
    Wang, S.
    Song, Y.
    Yu, Q.
    Tang, B.
    Wang, S.
    Wu, R.
    EUROPEAN HEART JOURNAL, 2018, 39 : 727 - 727
12345